AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Jan Biegus

Jan Biegus

Medical University of Wroclaw - Wroclaw / Poland
Others
AD Scientific Index ID: 908373
Uniwersytet Medyczny we Wrocławiu
person_outline Jan Biegus's MOST POPULAR ARTICLES
1-) The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial Nature medicine 28 (3), 568-574, 2022
2-) Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart … European heart journal 35 (36), 2468-2476, 2014
3-) Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial European heart journal 44 (1), 41-50, 2023
4-) Increased blood lactate is prevalent and identifies poor prognosis in patients with acute heart failure without overt peripheral hypoperfusion European journal of heart failure 20 (6), 1011-1018, 2018
5-) Effects of empagliflozin on symptoms, physical limitations, and quality of life in patients hospitalized for acute heart failure: results from the EMPULSE trial Circulation 146 (4), 279-288, 2022